chr19-50328956-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004977.3(KCNC3):​c.127C>T​(p.Pro43Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000245 in 877,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00098 ( 0 hom., cov: 24)
Exomes 𝑓: 0.000097 ( 0 hom. )

Consequence

KCNC3
NM_004977.3 missense

Scores

1
2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0480

Publications

0 publications found
Variant links:
Genes affected
KCNC3 (HGNC:6235): (potassium voltage-gated channel subfamily C member 3) The Shaker gene family of Drosophila encodes components of voltage-gated potassium channels and is comprised of four subfamilies. Based on sequence similarity, this gene is similar to one of these subfamilies, namely the Shaw subfamily. The protein encoded by this gene belongs to the delayed rectifier class of channel proteins and is an integral membrane protein that mediates the voltage-dependent potassium ion permeability of excitable membranes. Alternate splicing results in several transcript variants. [provided by RefSeq, Mar 2014]
KCNC3 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 13
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.031967282).
BP6
Variant 19-50328956-G-A is Benign according to our data. Variant chr19-50328956-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 447619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000985 (144/146212) while in subpopulation AFR AF = 0.00333 (136/40790). AF 95% confidence interval is 0.00288. There are 0 homozygotes in GnomAd4. There are 66 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High AC in GnomAd4 at 144 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNC3NM_004977.3 linkc.127C>T p.Pro43Ser missense_variant Exon 1 of 5 ENST00000477616.2 NP_004968.2 Q14003
KCNC3NM_001372305.1 linkc.-102C>T 5_prime_UTR_variant Exon 1 of 5 NP_001359234.1
KCNC3NR_110912.2 linkn.68+4513C>T intron_variant Intron 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNC3ENST00000477616.2 linkc.127C>T p.Pro43Ser missense_variant Exon 1 of 5 1 NM_004977.3 ENSP00000434241.1 Q14003
KCNC3ENST00000670667.1 linkc.127C>T p.Pro43Ser missense_variant Exon 1 of 4 ENSP00000499301.1 A0A590UJ62
KCNC3ENST00000376959.6 linkc.127C>T p.Pro43Ser missense_variant Exon 1 of 5 5 ENSP00000366158.2 E7ETH1
KCNC3ENST00000474951.1 linkc.-75+4513C>T intron_variant Intron 1 of 3 2 ENSP00000432438.1 E9PQY4

Frequencies

GnomAD3 genomes
AF:
0.000958
AC:
140
AN:
146122
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000339
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00150
GnomAD4 exome
AF:
0.0000971
AC:
71
AN:
731360
Hom.:
0
Cov.:
10
AF XY:
0.0000992
AC XY:
35
AN XY:
352716
show subpopulations
African (AFR)
AF:
0.00385
AC:
54
AN:
14022
American (AMR)
AF:
0.00
AC:
0
AN:
2802
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6406
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9760
South Asian (SAS)
AF:
0.00
AC:
0
AN:
17610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8672
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1710
European-Non Finnish (NFE)
AF:
0.0000109
AC:
7
AN:
643938
Other (OTH)
AF:
0.000378
AC:
10
AN:
26440
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000985
AC:
144
AN:
146212
Hom.:
0
Cov.:
24
AF XY:
0.000928
AC XY:
66
AN XY:
71140
show subpopulations
African (AFR)
AF:
0.00333
AC:
136
AN:
40790
American (AMR)
AF:
0.000339
AC:
5
AN:
14758
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3398
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5032
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4792
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8512
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65720
Other (OTH)
AF:
0.00149
AC:
3
AN:
2020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00135
Hom.:
0
Bravo
AF:
0.00122

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 13, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 25, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Nov 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.11
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.045
N
LIST_S2
Benign
0.42
T;T
M_CAP
Uncertain
0.26
D
MetaRNN
Benign
0.032
T;T
MetaSVM
Uncertain
-0.19
T
MutationAssessor
Benign
0.0
.;N
PhyloP100
0.048
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-0.73
N;N
REVEL
Benign
0.27
Sift
Benign
0.039
D;D
Sift4G
Benign
0.60
T;T
Polyphen
0.0
.;B
Vest4
0.14
MutPred
0.21
Gain of phosphorylation at P43 (P = 0.011);Gain of phosphorylation at P43 (P = 0.011);
MVP
0.57
ClinPred
0.077
T
GERP RS
-1.1
PromoterAI
-0.070
Neutral
Varity_R
0.047
gMVP
0.14
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs928573902; hg19: chr19-50832213; API